null Robyn Tamblyn, MScN, M.Sc., PhD, CM

Senior Scientist, RI-MUHC

Cardiovascular Health Across the Lifespan Program

Centre for Outcomes Research and Evaluation

Professor, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University

Department of Medicine, Division of Clinical Epidemiology, MUHC



health services • medical education • medical informatics • practice changes • pharmacoepidemiology

Research Focus

My research focuses on conducting observational and interventional studies in public health and health services delivery aimed at improving the safety and quality of health care. My research program aims to identify modifiable determinants of adverse events and improved health outcomes through the analysis of large linked clinical and administrative databases. My team develops and evaluates computer-enabled interventions to address modifiable risk factors (e.g., computerized decision-support, personal health record portals and self-management tools, automated surveillance systems).

Selected Publications

Click on Pubmed to see my current publications list

  • Tamblyn R, Eguale T, Huang A, et al. (2014) The Incidence and Determinants of Primary Non-Adherence with Prescribed Medication in Primary Care: A Cohort Study. Annals of Internal Medicine. Vol. 160(7).

  • Tamblyn R, Winslade N, Qian CJ, Moraga T, Huang A (2017) What is in your wallet? A cluster randomized trial of the effects of showing comparative patient out-of-pocket costs on primary care prescribing for uncomplicated hypertension. Implementation Science. Vol. 13:7.

  • Tamblyn R, Girard N, Dixon WG, et al. (2016) Pharmacosurveillance without borders: electronic health records in different countries can be used in estimating the risk of adverse events. Journal of Clinical Epidemiology. Vol. 77.

  • Wong J, Motulsky A, Eguale T, Buckeridge D, Abrahamowicz M, Tamblyn R (2016) Treatment Indications for Antidepressants Prescribed in Primary Care in Quebec, Canada, 2006-2015. Journal of the American Medical Association. Vol. 315(20).

  • Tamblyn R, Abrahamowicz M, Buckeridge DL, et al. (2019) Effect of an Electronic Medication Reconciliation Intervention on Adverse Drug Events: A Cluster Randomized Trial. JAMA Open. Vol.2(9).